Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
8.39
+0.48 (6.07%)
At close: Jun 26, 2026, 4:00 PM EDT
8.31
-0.08 (-1.00%)
After-hours: Jun 26, 2026, 7:57 PM EDT
Teladoc Health Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for Teladoc Health stock have an average target of 7.47, with a low estimate of 5.00 and a high estimate of 11. The average target predicts a decrease of -10.97% from the current stock price of 8.39.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Teladoc Health stock from 25 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 6 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 22 | 21 | 19 | 19 | 19 | 18 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 27 | 27 | 26 | 26 | 26 | 25 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Hold Reiterates $9 | Hold | Reiterates | $9 | +7.27% | Jun 1, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $8.25 → $9 | Buy | Maintains | $8.25 → $9 | +7.27% | May 29, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $7 → $8 | Buy | Maintains | $7 → $8 | -4.65% | May 27, 2026 |
| UBS | UBS | Hold Maintains $6 | Hold | Maintains | $6 | -28.49% | May 15, 2026 |
| Citi | Citi | Hold Reiterates $6 → $7 | Hold | Reiterates | $6 → $7 | -16.57% | May 5, 2026 |
Financial Forecast
Revenue This Year
2.51B
from 2.53B
Decreased by -0.96%
Revenue Next Year
2.54B
from 2.51B
Increased by 1.25%
EPS This Year
-0.79
from -0.66
EPS Next Year
-0.65
from -0.79
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.5B | 2.6B | |
| Avg | 2.5B | 2.5B | |
| Low | 2.5B | 2.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.1% | 3.7% | |
| Avg | -1.0% | 1.2% | |
| Low | -1.9% | -2.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.61 | -0.55 | |
| Avg | -0.79 | -0.65 | |
| Low | -0.89 | -0.78 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.